Skip to main content
    S

    Standard Biotools Inc (LAB)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.54
    -0.08 (-13.14%)

    Market Cap: $279.27M

    Last updated: Nov 17, 2026 at 4:32 PM ET

    Standard Biotools Inc (LAB) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Standard Biotools (LAB) has a latest price of $0.54 on Nov 17, 2026. Its price fell 56.5% over the past 12 months. The month-end price fell 69.3% over the 3 years through Oct 2026, a compound annual decline of 32.6%.

    Price Chart

    From Apr 2022 to Oct 2026, its highest month-end close was $3.00 in Aug 2023 and its lowest $0.61 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart LAB with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for LAB.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 19.7%, and over 6 months it fell 46.1%.

    PeriodChange
    1 month-16.2%
    3 months-19.7%
    6 months-46.1%
    12 months-56.5%
    12 months, with dividends-56.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-69.3%-32.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 88.9%, and its weakest was 2025, when it fell 26.9%.

    YearCloseChange
    2026 through Oct 2026$0.61-52.3%
    2025$1.28-26.9%
    2024$1.75-20.8%
    2023$2.21+88.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 19.9% below its 50-day average of $0.67 and 37.5% below its 200-day average of $0.86.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.54
    50-day average$0.67-19.9%
    200-day average$0.86-37.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 81.5%.

    MeasureValue
    1-year beta1.17
    Largest fall, 1 year-67.9%
    Largest fall, 3 years-81.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About LAB

    What is LAB's 1-year price change?

    Standard Biotools's price fell 56.5% over the past 12 months. With dividends included, the 12-month total return was -56.5%.

    How has LAB stock done over the long term?

    Standard Biotools's month-end price fell 69.3% over the 3 years through Oct 2026, a compound annual decline of 32.6%. These figures leave out dividends.

    What is LAB's beta?

    Standard Biotools's 1-year beta against the S&P 500 is 1.17, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 67.9%.

    Is the LAB chart free?

    Yes. Advanced Charting for LAB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.